Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
J&J nears sweeping resolution to long-standing talc litigation
Johnson & Johnson is on the cusp of settling more than 50,000 lawsuits linking its popular talc-based baby powder to ovarian cancer.
Fraiser Kansteiner
May 1, 2024 10:55am
100 not out: J&J celebrates UK centenary with new name and look
May 1, 2024 3:00am
J&J, BMS set to appeal losses in IRA drug pricing lawsuits
Apr 30, 2024 11:48am
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
AbbVie tops, J&J drops as physicians rank immunology players
Apr 19, 2024 7:30am
J&J reports $133M in sales for new multiple myeloma med Tecvayli
Apr 16, 2024 11:28am